On November 10, 2020 Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated ImmTOR platform to develop tolerogenic therapies that selectively mitigate unwanted immune responses, reported that Selecta’s Chief Executive Officer, Carsten Brunn, Ph.D., will participate virtually in the following investor conferences in November (Press release, Selecta Biosciences, NOV 10, 2020, View Source [SID1234570470]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Jefferies Virtual London Healthcare Conference
Date: Tuesday, November 17, 2020
Presentation time: 9:05 a.m. ET
Stifel 2020 Virtual Healthcare Conference
Date: Wednesday, November 18, 2020
Fireside chat time: 2 p.m. ET
Live webcasts will be available in the Investors & Media section of the company’s website at www.selectabio.com.